[Clinical experiences with Voltaren a new nonsteroid antirheumatic agent].
D000814:Aniline Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001241:Aspirin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000139:chemically induced; D004341:Drug Evaluation; D004361:Drug Tolerance; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced; D010648:Phenylacetates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D010648:Phenylacetates; D001241:Aspirin; D007213:Indomethacin
Klinische Erfahrungen mit Voltaren, einem neuen nicht-steroiden Antirheumatikum